论文部分内容阅读
目的 探讨合理情绪行为疗法 (REBT)对偏头痛的近远期疗效。方法 86例偏头痛患者随机分为REBT组、药物组各 43例 ,REBT组 :采用REBT治疗 ,2次 /周 ;药物组 :阿米替林 5 0～ 10 0mg/天、尼莫地平 6 0mg/天 ,均治疗 12周 ,并设 30例健康对照组。于治疗前、治疗 12周后、停止治疗后第 12周分别行SCL 90、偏头痛疗效评分 (TSSM)及P3 0 0 检测。结果 两组患者SCL 90总均分明显高于对照组 ;经治 12周 ,两组患者TSSM、SCL 90总均分及主要因子分均显著降低 ,两组间无显著差异 ;停止治疗后第 12周 ,REBT组SCL 90总均分及主要因子分、TSSM、P3 0 0 潜伏期与其治疗时相比基本相同 ,P3 0 0 波幅亦显著增高 ,而药物组SCL 90总均分及主要因子分、TSSM与其治疗时相比显著增高 ,两组同期相比差异显著。结论 REBT能改善患者认知功能障碍 ,REBT与阿米替林对偏头痛近期疗效相似 ,但远期疗效REBT优于药物治疗
Objective To explore the short-term and long-term effects of rational emotional behavior therapy (REBT) on migraine. Methods Eighty-six patients with migraine were randomly divided into three groups: REBT group (n = 43), REBT group (n = 23) and REBT group / Day, were treated for 12 weeks, and 30 cases of healthy control group. Before treatment, after 12 weeks of treatment, SCL 90, migraine headache efficacy score (TSSM) and P3 0 0 were measured at the 12th week after stopping the treatment. Results The total score of SCL 90 in the two groups was significantly higher than that in the control group. After 12 weeks of treatment, the mean and the major factors of TSSM and SCL 90 were significantly decreased in both groups, with no significant difference between the two groups. After stopping treatment, The total SCL 90 and major factor scores, TSSM and P3 0 0 latency in REBT group were basically the same as those in the treatment group, and the amplitudes of P3 0 0 were also significantly increased in the REBT group. However, the mean and median scores of SCL 90, TSSM Compared with the time of treatment, the difference between the two groups was significant. Conclusion REBT can improve cognitive dysfunction in patients with REBT and amitriptyline on the recent efficacy of migraine similar, but long-term efficacy of REBT better than drug treatment